Blood dialyzer is a medical device used to remove excess waste and fluid from the blood of patients with kidney failure. The global blood dialyzer market is driven by the increasing prevalence of chronic kidney diseases and the growing geriatric population. Technological advancements in the field of blood dialysis and the rising demand for home dialysis treatments are also fueling market growth. Moreover, the growing demand for blood dialyzers in emerging economies and the increasing number of product launches and partnerships among key players are further contributing to market growth. However, the high cost of blood dialysis treatment and the risks associated with dialysis procedures may hinder market growth. Nonetheless, the increasing adoption of online hemodiafiltration (HDF) and the development of portable and wearable blood dialyzers are expected to offer significant growth opportunities in the blood dialyzer market.
Global Blood Dialyzer Market size is valued at US$ 6,241.9 million in 2022 and is expected to witness a CAGR of 6.3% over the forecast period (2022 – 2030).
Leading Companies in the Blood Dialyzer Industry:
1. In 2021, Fresenius Medical Care AG & Co. KGaA announced that it is collaborating with Humacyte, Inc. to develop a blood dialyzer made from investigational human acellular vessels (HAVs). The companies plan to conduct a clinical study to assess the safety and efficacy of the blood dialyzer.
2. Baxter International, Inc. was founded in 1931 and is headquartered in Deerfield, Illinois, USA. The company operates in more than 100 countries and is a leading manufacturer of medical products and devices. In 2020, Baxter announced the launch of its new hemodialysis system, AK 98. The system is designed to provide better outcomes for patients with end-stage renal disease.
3. Nikkiso Co. Ltd. was founded in 1953 and is headquartered in Tokyo, Japan. The company operates in more than 13 countries and specializes in the manufacture of medical equipment, including blood dialyzers. In 2020, Nikkiso announced that it had received approval from the US Food and Drug Administration (FDA) for its DBB-06 dialyzer. The DBB-06 is a high-performance dialyzer designed to improve the clearance of small and middle molecules.
4. B. Braun SE was founded in 1839 and is headquartered in Melsungen, Germany. The company operates in more than 60 countries and is a leading manufacturer of medical products and devices. In 2021, B. Braun announced that it had acquired the hemodialysis business of NxStage Medical, Inc. The acquisition is expected to expand B. Braun's product portfolio in the hemodialysis market.
5. CVS Health is headquartered in Woonsocket, Rhode Island, USA, and operates more than 9,900 pharmacies in the United States. In 2021, CVS Health announced that it had partnered with Walgreens Boots Alliance and Walmart to offer kidney care services in a pilot program. The program is designed to help patients with chronic kidney disease receive better care and support.
6. Nipro Corporation was founded in 1954 and is headquartered in Osaka, Japan. The company operates in more than 26 countries and specializes in the manufacture of medical equipment, including blood dialyzers. In 2021, Nipro announced that it had received approval from the US FDA for its Elisio dialyzer. The Elisio is a high-flux dialyzer designed to improve the removal of uremic toxins.
7. Diaverum Deutschland GmbH is headquartered in Munich, Germany, and operates more than 400 dialysis centers in 22 countries. In 2021, Diaverum announced that it had acquired Swedish medtech company Nexadia. The acquisition is expected to enhance Diaverum's digital capabilities in the renal care space.
8. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts, USA. The company specializes in the manufacture of hemodial
*Definition- A blood dialyzer is a medical device used in hemodialysis to remove waste and excess fluids from the blood of patients with kidney failure. It works by filtering blood through a semipermeable membrane and removing toxins, excess fluids, and other impurities from the bloodstream.
